+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Multi system stem cell following apparent recovery from alkylating agents



Multi system stem cell following apparent recovery from alkylating agents



Radiation Research 70(3): 662




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 026999877

Download citation: RISBibTeXText


Related references

Multi system stem cell failure following apparent recovery from alkylating agents. Proceedings of the American Association for Cancer Research 18: 121, 1977

Multi system stem cell failure after apparent recovery from alkylating agents. Cancer Research 38(7): 1942-1947, 1978

Comparisons of the biological effects of ionizing radiations and certain alkylating agents in cell system. In: Comparative clinical and biological effects of alkylating agents. Ann New York Acad Sci 68(3): 702-720, 1958

Transfection of murine multi-potent haemopoietic stem cells with an E. coli DNA alkyltransferase gene confers resistance to the toxic effects of alkylating agents. Carcinogenesis 9(1): 81-87, 1988

Cell survival recovery kinetics in the kht sarcoma following treatment with 5 alkylating agents and misonidazole. International Journal Of Radiation Oncology, Biology, Physics: 619-622, 1982

Cell survival recovery kinetics in the KHT sarcoma following treatment with five alkylating agents and misonidazole. International Journal of Radiation Oncology Biology Physics 8(3-4): 619-622, 1982

Genomic phenotyping by barcode sequencing broadly distinguishes between alkylating agents, oxidizing agents, and non-genotoxic agents, and reveals a role for aromatic amino acids in cellular recovery after quinone exposure. Plos one 8(9): E73736, 2013

Transcriptional blockages in a cell-free system by sequence-selective DNA alkylating agents. Chemico-Biological Interactions 126(1): 15-31, 2000

Multiple organ failure presumably due to alkylating agents used as preconditioning drugs for autologous peripheral blood stem cell transplantation in an acute promyelocytic leukemia. Japanese Journal of Clinical Hematology 57(1): 41-46, 2016

Retrovirus-mediated transfer of the human O-6-methylguanine-DNA methyltransferase gene into a murine hematopoietic stem cell line and resistance to the toxic effects of certain alkylating agents. Biochemical Pharmacology 51(9): 1221-1228, 1996

Overexpression of erb B2 remains a major risk factor in non-metastatic breast cancers treated with high-dose alkylating agents and autologous stem cell transplantation. Bone Marrow Transplantation 29(9): 753-757, 2002

High-dose alkylating agents with autologous hematopoietic stem cell support and trastuzumab in ERBB2 overexpressing metastatic breast cancer: a feasibility study. Anticancer Research 25(1b): 663-667, 2005

Enhanced sensitivity of the C3H/10T1/2 cell transformation system to alkylating and chemotherapeutic agents by treatment with 12-O-tetradecanoylphorbol-13-acetate. Environmental Mutagenesis 6(1): 81-89, 1984